Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

158
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
158
Vaccines01:21

Vaccines

105
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
105
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Return on investment of enhanced primary youth mental health services in a large Canadian urban centre: a retrospective cohort study.

The lancet. Psychiatry·2026
Same author

Readiness to Consider and Adopt Genetic and Genomic Tests in Canada-An Update to the State of Readiness Report.

Current oncology (Toronto, Ont.)·2026
Same author

Return on Investment of the Endovascular Therapy Within 6-24 h Treatment Window in Alberta, Canada.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Health-Related Outcome Improvements Via the ACCESS Open Minds Youth Mental Health Service Transformation Project in Edmonton, Canada: Amélioration des résultats en matière de santé grâce au projet de transformation des services de santé mentale jeunes d'ACCESS Open Minds/Esprits ouverts à Edmonton, Canada.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

Rationally designed minimized TbpB confers broad protection against meningococcal infection.

bioRxiv : the preprint server for biology·2025
Same author

Structure-based engineering of a nutrient acquisition protein enhances neutralizing antibodies and protection for the development of a gonococcal vaccine.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: May 6, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

7.6K

Vaccine development costs: a review.

Arianna Waye1, Philip Jacobs, Anthony B Schryvers

  • 1Department of Medicine, University of Alberta, Edmonton, AB, T5J 3N4, Canada.

Expert Review of Vaccines
|October 29, 2013
PubMed
Summary
This summary is machine-generated.

Estimating vaccine development costs is crucial for informing government policy. This paper reviews drug and vaccine research and development (R&D) costs to guide financial and regulatory decisions in the vaccine industry.

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.3K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.9K

Related Experiment Videos

Last Updated: May 6, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

7.6K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.3K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

2.9K

Area of Science:

  • Pharmaceutical Economics
  • Vaccinology
  • Health Policy

Background:

  • Drug development costs are widely estimated at US$800 million to US$1.8 billion.
  • Vaccine development cost estimations are lacking, creating uncertainty about industry financial comparisons.
  • Financial and regulatory policies critically influence pharmaceutical development scope and expenses.

Purpose of the Study:

  • To review the concept of drug and vaccine research and development (R&D) costs.
  • To synthesize existing literature on R&D expenditures in the pharmaceutical and vaccine sectors.
  • To inform vaccine industry financial and regulatory policy through a cost analysis.

Main Methods:

  • Literature review of drug and vaccine R&D cost studies.
  • Comparative analysis of cost factors in drug versus vaccine development.
  • Examination of the impact of financial and regulatory policies on R&D investments.

Main Results:

  • Significant data gaps exist for vaccine R&D cost estimations.
  • The economic landscape of vaccine development requires further elucidation.
  • Policy decisions necessitate a clearer understanding of vaccine development economics.

Conclusions:

  • Accurate vaccine R&D cost data is essential for effective government policy-making.
  • Understanding these costs will aid in navigating the financial and regulatory environment of the vaccine industry.
  • Further research is needed to establish reliable vaccine development cost benchmarks.